{"id":"fenethazine","rwe":[],"tags":[{"label":"fenethazine","category":"class"},{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"phase_2","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"allNames":"rutergan","offLabel":[],"synonyms":["fenethazine","phenetazine","phenethazine","phenethazinum","rutergan"],"timeline":[],"approvals":[],"brandName":"Rutergan","ecosystem":[],"mechanism":{"modality":"Small Molecule","drugClass":"fenethazine","explanation":"Imagine your body's cells have locks on them, and fenethazine is a key that fits into one of those locks. When it binds to the lock, it can either turn the lock open or closed, depending on the type of lock and the key's shape. This can affect how cells behave and communicate with each other, but the exact details of how fenethazine works are still a mystery.","oneSentence":"Fenethazine is thought to work by interacting with a specific target in the body, although its exact mechanism of action is not well understood.","technicalDetail":"Fenethazine is a phenothiazine derivative that may interact with various molecular targets, including neurotransmitter receptors and ion channels, to produce its therapeutic effects."},"commercial":{},"references":[{"id":1,"url":"https://drugcentral.org/drugcard/3747","fields":["approvals","synonyms","ATC","PK","indications","contraindications","DDIs","targets","patents","FAERS"],"source":"DrugCentral"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=FENETHAZINE","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-30T11:25:29.124206","biosimilars":[],"competitors":[],"genericName":"fenethazine","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"UNII":"8J97CUZ4HX","CHEBI":"CHEBI:135112","INN_ID":"1860","UMLSCUI":"C0060166","ChEMBL_ID":"CHEMBL2106299","KEGG_DRUG":"D02602","PUBCHEM_CID":"68223","MESH_SUPPLEMENTAL_RECORD_UI":"C014551"},"formularyStatus":[],"_enricherVersion":"v2","developmentCodes":[],"ownershipHistory":[],"publicationCount":2,"therapeuticAreas":["Neuroscience"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"active","companyName":"","companyId":"","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Fenethazine is a small molecule drug in the fenethazine class, but its target and exact mechanism of action are unknown. It is not clear if it is FDA-approved or commercially available. Fenethazine is not a well-documented drug, and its pharmacokinetic properties, such as half-life and bioavailability, are also unknown. As a result, there is limited information available on its approved indications, generic manufacturers, or patent status. Further research is needed to understand the clinical utility and safety profile of fenethazine.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"partial","dataCompleteness":{"mechanism":true,"indications":false,"safety":false,"trials":false,"score":1}}